Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
If your spending outpaced your income, you're not alone. Here are simple first steps to recover quickly when What To Do When Your Budget Fails and rebuild a sustainable plan.
16,925 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A new analysis identifies five cities that nail retirement by offering affordable homes, solid healthcare, and senior...
Palantir stock soared today as investors priced in a mix of solid results, new government and enterprise wins, and a ...
As volatility stays elevated, a hedge against rising option premiums is gaining attention. The 8%-yield S&P 500 Premi...
A 74-year-old attorney clears $900,000 from a property sale but faces retirement planning gaps. Dave Ramsey prescribe...
A timely macro rebuttal from Citadel Securities challenges a viral AI-doomsday scenario, arguing that current data sh...
Adobe stock dropped after earnings despite solid results, leaving many investors puzzled. This article unpacks the fo...
Rumors swirl about SpaceX planning an IPO at a staggering $1.75 trillion. This article breaks down what that would me...
A new energy setback from the Iran conflict is reverberating worldwide. Global flows are disrupted, prices move, and ...
Medicare Part B costs are climbing in 2026, pulling more from Social Security checks and narrowing the real value of ...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...